Integrated efficacy analysis of 24-week data from two phase 2 and one phase 3 clinical trials of bulevirtide monotherapy given at 2 mg or 10 mg dose level for treatment of chronic hepatitis delta

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2022-07, Vol.77, p.S828
Main Authors: Lampertico, Pietro, Aleman, Soo, Blank, Antje, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Viacheslav, Morozov, Sagalova, Olga, Stepanova, Tatyana, Suri, Vithika, Manuilov, Dmitry, Ye, Lei, Flaherty, John F., Osinusi, Anu, Cornberg, Markus, Brunetto, Maurizia, Wedemeyer, Heiner
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
DOI:10.1016/S0168-8278(22)01953-5